Abstract
Purpose
Several species of rodents are used to investigate the metabolism of quercetin in vivo. However, it is unclear whether they are a proper animal model. Thus, we compared the metabolism of quercetin in Wistar rats (rats), Balb/c mice (mice) and Mongolian gerbils (gerbils).
Methods
We determined the levels of quercetin metabolites, quercetin-3-glucuronide (Q3G), quercetin-3′-sulfate (Q3′S) and methyl-quercetin isorhamnetin (IH), in the plasma, lungs and livers of three species of animals by high-performance liquid chromatography after acute and/or chronic quercetin administration. The metabolic enzyme activities in the intestinal mucosal membrane and liver were also investigated.
Results
First, we found that after acute quercetin administration, the Q3′S level was the highest in gerbils. However, after long-term supplementation (20 weeks), Q3G was the dominant metabolite in the plasma, lungs and livers followed by IH and Q3′S in all animals, although the gerbils still had a higher Q3′S conversion ratio. The average concentrations of total quercetin concentration in the plasma of gerbils were the highest in both short- and long-term studies. The activities of uridine 5′-diphosphate-glucuronosyltransferase, phenolsulfotransferase and catechol-O-methyltransferase were induced by quercetin in a dose- and tissue-dependent manner in all animals.
Conclusions
Taken together, in general, after long-term supplementation the metabolism of quercetin is similar in all animals and is comparable to that of humans. However, the accumulation of quercetin and Q3′S conversion ratio in gerbils are higher than those in the other animals.
Similar content being viewed by others
Abbreviations
- Q3G:
-
Quercetin-3-glucuronide
- Q3′S:
-
Quercetin-3′-sulfate
- IH:
-
Isorhamnetin
- QA:
-
Quercetin aglycone
- Rats:
-
Wistar rats
- Mice:
-
Balb/c mice
- Gerbils:
-
Mongolian gerbils
- UDPGT:
-
Uridine 5′-diphosphate-glucuronosyltransferase
- PST:
-
Phenolsulfotransferase
- COMT:
-
Catechol-O-methyltransferase
- UDPGA:
-
Uridine 5′-diphosphoglucuronic acid
References
Arts IC, Hollman PC (2005) Polyphenols and disease risk in epidemiologic studies. Am J Clin Nutr 81:317S–325S
Vauzour D, Rodriguez-Mateos A, Corona G et al (2010) Polyphenols and human health: prevention of disease and mechanisms of action. Nutrients 2:1106–1131
Knekt P, Järvinen R, Seppänen R et al (1997) Dietary flavonoids and the risk of lung cancer and other malignant neoplasms. Am J Epidemiol 146:223–230
Lakhanpal P, Rai DK (2007) Quercetin: a versatile flavonoid. Internet J Med Update 2:22–37
Ross JA, Kasum CM (2002) Dietary flavonoids: bioavailability, metabolic effects, and safety. Annu Rev Nutr 22:19–34
Xu R, Zhang Y, Ye X et al (2013) Inhibition effects and induction of apoptosis of flavonoids on the prostate cancer cell line PC-3 in vitro. Food Chem 138:48–53
Thilakarathna SH, Rupasinghe HP, Needs PW (2013) Apple peel bioactive rich extracts effectively inhibit in vitro human LDL cholesterol oxidation. Food Chem 138:463–470
Day AJ, Mellon F, Barron D et al (2001) Human metabolism of dietary flavonoids: identification of plasma metabolites of quercetin. Free Radic Res 35:941–952
Murota K, Terao J (2003) Antioxidative flavonoid quercetin: implication of its intestinal absorption and metabolism. Arch Biochem Biophys 417:12–17
Graefe EU, Wittig J, Mueller S et al (2001) Pharmacokinetics and bioavailability of quercetin glycosides in humans. J Clin Pharmacol 41:492–499
Terao J, Murota K, Kawai Y (2011) Conjugated quercetin glucuronides as bioactive metabolites and precursors of aglycone in vivo. Food Funct 2:11–17
Suri S, Liu XH, Rayment S et al (2010) Quercetin and its major metabolites selectively modulate cyclic GMP-dependent relaxations and associated tolerance in pig isolated coronary artery. Br J Pharmacol 159:566–575
Yeh SL, Yeh CL, Chan ST et al (2011) Plasma rich in quercetin metabolites induces G2/M arrest by up-regulating PPAR-γ expression in human A549 lung cancer cells. Planta Med 77:992–998
de Boer VC, Dihal AA, van der Woude H et al (2005) Tissue distribution of quercetin in rats and pigs. J Nutr 135:1718–1725
Bieger J, Cermak R, Blank R et al (2008) Tissue distribution of quercetin in pigs after long-term dietary supplementation. J Nutr 138:1417–1420
Day AJ, Bao Y, Morgan MR et al (2000) Conjugation position of quercetin glucuronides and effect on biological activity. Free Radic Biol Med 29:1234–1243
Chen YK, Chen SQ, Li X et al (2005) Quantitative regioselectivity of glucuronidation of quercetin by recombinant UDP-glucuronosyltransferases 1A9 and 1A3 using enzymatic kinetic parameters. Xenobiotica 35:943–954
Chang YZ, Lin HC, Chan ST et al (2012) Effects of quercetin metabolites on the enhancing effect of β-carotene on DNA damage and cytochrome P1A1/2 expression in benzo[a]pyrene-exposed A549 cells. Food Chem 133:445–450
Piskula MK, Terao J (1998) Accumulation of (−)-epicatechin metabolites in rat plasma after oral administration and distribution of conjugation enzymes in rat tissues. J Nutr 128:1172–1178
Lowry OH, Rosebrough NJ, Farr AL et al (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275
Egert S, Wolffram S, Bosy-Westphal A et al (2008) Daily quercetin supplementation dose-dependently increases plasma quercetin concentrations in healthy humans. J Nutr 138:1615–1621
Lee J, Ebeler SE, Zweigenbaum JA et al (2012) UHPLC-(ESI) QTOF MS/MS profiling of quercetin metabolites in human plasma postconsumption of applesauce enriched with apple peel and onion. J Agric Food Chem 60:8510–8520
Nakamura T, Murota K, Kumamoto S et al (2014) Plasma metabolites of dietary flavonoids after combination meal consumption with onion and tofu in humans. Mol Nutr Food Res 58:310–317
Moon YJ, Wang L, DiCenzo R et al (2008) Quercetin pharmacokinetics in humans. Biopharm Drug Dispos 29:205–217
Mullen W, Edwards CA, Crozier A (2006) Absorption, excretion and metabolite profiling of methyl-, glucuronyl-, glucosyland sulpho-conjugates of quercetin in human plasma and urine after ingestion of onions. Br J Nutr 96:107–116
Cialdella-Kam L, Nieman DC, Sha W et al (2013) Dose-response to 3 months of quercetin-containing supplements on metabolite and quercetin conjugate profile in adults. Br J Nutr 109:1923–1933
Williamson G, Manach C (2005) Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies. Am J Clin Nutr 81:243S–255S
Kawai Y, Nishikawa T, Shiba Y et al (2008) Macrophage as a target of quercetin glucuronides in human atherosclerotic arteries: implication in the anti-atherosclerotic mechanism of dietary flavonoids. J Biol Chem 283:9424–9434
Chan ST, Lin YC, Chuang CH et al (2014) Oral and intraperitoneal administration of quercetin decreased lymphocyte DNA damage and plasma lipid peroxidation induced by TSA in vivo. Biomed Res Int 2014:580626
Dajas F, Andrés AC, Florencia A (2013) Neuroprotective actions of flavones and flavonols: mechanisms and relationship to flavonoid structural features. Cent Nerv Syst Agents Med Chem 13:30–35
Sak K (2014) Site-specific anticancer effects of dietary flavonoid quercetin. Nutr Cancer 66:177–193
Kaminsky LS, Zhang QY (2003) The small intestine as a xenobiotic-metabolizing organ. Drug Metab Dispos 31:1520–1525
van der Logt EM, Roelofs HM, Nagengast FM et al (2003) Induction of rat hepatic and intestinal UDP-glucuronosyltransferases by naturally occurring dietary anticarcinogens. Carcinogenesis 24:1651–1656
Fisher MB, Vandenbranden M, Findlay K et al (2000) Tissue distribution and interindividual variation in human UDP- glucuronosyltransferase activity: relationship between UGT1A1 promoter genotype and variability in a liver bank. Pharmacogenetics 10:727–739
Grams B, Harms A, Braun S et al (2000) Distribution and inducibility by 3-methylcholanthrene of family 1 UDP-glucuronosyltransferases in the rat gastrointestinal tract. Arch Biochem Biophys 377:255–265
Bursztyka J, Perdu E, Pettersson K et al (2008) Biotransformation of genistein and bisphenol A in cell lines used for screening endocrine disruptors. Toxicol In Vitro 22:1595–1604
Lu H, Meng X, Yang CS (2003) Enzymology of methylation of tea catechins and inhibition of catechol-O-methyltransferase by (−)-epigallocatechin gallate. Drug Metab Dispos 31:572–579
Männistö PT, Kaakkola S (1999) Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors. Pharmacol Rev 51:593–628
Acknowledgments
This study was supported by a Grant (NSC-98-2320-B- 241-001-MY3) from the National Science Council, Republic of China. Liquid chromatography-mass spectrometry was performed in the Instrument Center at Chung Shan Medical University, which is supported by the National Science Council, Ministry of Education and Chung Shan Medical University.
Conflict of interest
The authors declare no financial conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yeh, SL., Lin, YC., Lin, YL. et al. Comparing the metabolism of quercetin in rats, mice and gerbils. Eur J Nutr 55, 413–422 (2016). https://doi.org/10.1007/s00394-015-0862-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00394-015-0862-9